Skip to main content

Student Transportation has 11,500 vehicles in Ontario and a number of U.S. states.

Ian Sorensen/The Globe and Mail

Hudbay Minerals Inc. (HBM-T; HBM-N) says it has acquired about 10.8 million common shares of Mason Resources Corp. (MNR-T) – or about 14 per cent of the company.

It bought the shares for 26 cents each, for total consideration of about $2.8-million.

"The acquisition of the shares is being made for investment purposes," the company stated.

Story continues below advertisement

***

Sandstorm Gold Ltd. (SSL-T) says it sold 10.8 million common shares of Mason Resources Corp. (MNR-T) for gross proceeds of $2.8-million.

The company said the sale reduces its holdings of Mason common shares to zero. It still holds 200,000 share purchase warrants of Mason.

"The sale of Mason shares represents a continuation of Sandstorm's strategy to monetize non-core assets in order to fund the acquisition of streams and royalties," the company stated.

***

Student Transportation Inc. (STB-T; STB-Q) says its School Transportation Group subsidiary has closed the acquisition of a student transportation company, Maryland-based Annapolis Bus Company, Inc.

"With annual revenue of approximately $8.5-million (U.S.), the acquisition will add more than 125 revenue vehicles to STI's existing fleet," the company stated.

Story continues below advertisement

The company has multiple transportation contracts with the school district, STI said.

***

Hudson's Bay Co. (HBC-T) says HBC International president Don Watros "has made the decision to leave" the company, effective Sept. 29

"Don has been a great partner in supporting the growth and integration of HBC's businesses over the years and was instrumental in HBC entering Europe and helping to establish our structure there," said HBC executive chairman Richard Baker in a statement.

Mr. Watros has been with HBC for 11 years "and has seen the company through major growth," the company said.

He was appointed the president of HBC International in January 2015.

Story continues below advertisement

***

GreenSpace Brands Inc. (JTR-X) reported first-quarter revenue of $14.2-million, a record and an increase from $9.1-million a year ago.

Analysts were expecting revenue of $13.6-million in the most recent quarter.

"The growth experienced in the quarter in comparison to the same period in prior year was the result of continued strong growth from the GreenSpace core brands of Love Child, Central Roast, Rolling Meadow and Life Choices, along with incremental revenue growth from the Nothing But Nature acquisition," the company stated.

Its net loss was $241,000 or nil per share versus a loss of $601,000 or 2 cents a year earlier.

***

CannaRoyalty Corp. (CRZ-T) reported revenues of $960,157 in the second quarter as compared to $12,418 a year ago.

Its net loss was $2.5-million or 6 cents per share compared to a loss of $1-million or 6 cents a year ago.

**

Carmanah Technologies Corp. (CMH-T) says board chairman Michael Sonnenfeldt has announced his resignation effective immediately.

"As Carmanah's largest shareholder, Michael had a vision that Carmanah could become a world class designer, manufacturer and distributor of solar related infrastructure equipment that would represent the most environmentally sensitive and best economic alternative for our customers," said CEO John Simmons, who also credited him for "the transformation of Carmanah from a company with a history of losses to one that is now solidly profitable."

Mr. Sonnenfeldt stated that he felt "my work is now finished and I leave the company in great financial condition with an outstanding leadership team."

The company said entities controlled by Mr. Sonnenfeldt sold shares but "still remain significant shareholders" of Carmanah, owning about 10 per cent of its common shares.

Jim Meekison has been appointed the new board chairman. He is also a "significant Carmanah shareholder," the company said.

***

CanniMed Therapeutics Inc. (CMED-T) says it has signed a supply agreement with South Africa-based Akula Trading 2 Pty Ltd. to export sales of its oil products in Africa, with initial sales planned to be in South Africa.

"Today's announcement marks another very significant milestone in the company's international expansion plans," stated CanniMed CEO Brent Zettl in a release.

The company said medical cannabis is expected to be prescribed in South Africa through an application by a medical doctor and dispensed through pharmacy outlets nationally.

"CanniMed will additionally provide Akula management and their medical sales representatives with an educational program designed to support the full penetration of medical cannabis treatment to physicians and hospitals," it stated.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

If your comment doesn't appear immediately it has been sent to a member of our moderation team for review

Read our community guidelines here

Discussion loading…

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.